Production (Stage)
Aura Biosciences, Inc.
AURA
$5.89
-$0.05-0.84%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/24/2025
-
Tickeron - Stocks
5/23/2025
-
Ticker Report
5/22/2025
-
Simply Wall St
5/22/2025
-
Ticker Report
5/21/2025
-
MarketBeat
5/17/2025
-
MarketBeat
5/17/2025
-
TipRanks Financial Blog
5/16/2025
-
TipRanks Financial Blog
5/16/2025
-
MarketBeat
5/15/2025
-
TipRanks Financial Blog
5/15/2025
-
GuruFocus
5/15/2025
-
GuruFocus
5/15/2025
-
The Fly
5/15/2025
-
Globe Newswire
5/15/2025
-
Seeking Alpha - Healthcare
5/15/2025
-
GuruFocus
5/15/2025
-
GuruFocus
5/15/2025
-
GuruFocus
5/15/2025
-
GuruFocus
5/15/2025
-
GuruFocus
5/15/2025
-
GuruFocus
5/15/2025
-
TipRanks Financial Blog
5/15/2025
-
The Fly
5/15/2025
-
Globe Newswire
5/15/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 15, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 500 8864
Address
80 Guest Street
Boston, MA 02135
Boston, MA 02135
Country
Year Founded
Business Description
Sector
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company’s proprietary platform enables the targeting of a range of solid...
more